- Home
- PRZO vs JUNS Comparison
PRZO vs JUNS Comparison
Compare PRZO & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- JUNS
- Stock Information
- Founded
- PRZO 2014
- JUNS 2015
- Country
- PRZO Israel
- JUNS United States
- Employees
- PRZO N/A
- JUNS N/A
- Industry
- PRZO
- JUNS
- Sector
- PRZO
- JUNS
- Exchange
- PRZO Nasdaq
- JUNS NYSE
- Market Cap
- PRZO 20.1M
- JUNS 20.5M
- IPO Year
- PRZO 2023
- JUNS 2024
- Fundamental
- Price
- PRZO $1.61
- JUNS $2.37
- Analyst Decision
- PRZO
- JUNS
- Analyst Count
- PRZO 0
- JUNS 0
- Target Price
- PRZO N/A
- JUNS N/A
- AVG Volume (30 Days)
- PRZO 2.1M
- JUNS 723.2K
- Earning Date
- PRZO 09-02-2025
- JUNS 08-11-2025
- Dividend Yield
- PRZO N/A
- JUNS N/A
- EPS Growth
- PRZO N/A
- JUNS N/A
- EPS
- PRZO N/A
- JUNS N/A
- Revenue
- PRZO $932,154.00
- JUNS N/A
- Revenue This Year
- PRZO N/A
- JUNS N/A
- Revenue Next Year
- PRZO N/A
- JUNS N/A
- P/E Ratio
- PRZO N/A
- JUNS N/A
- Revenue Growth
- PRZO 50.22
- JUNS N/A
- 52 Week Low
- PRZO $0.49
- JUNS $0.51
- 52 Week High
- PRZO $3.16
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- PRZO 67.69
- JUNS N/A
- Support Level
- PRZO $1.37
- JUNS N/A
- Resistance Level
- PRZO $1.52
- JUNS N/A
- Average True Range (ATR)
- PRZO 0.10
- JUNS 0.00
- MACD
- PRZO 0.03
- JUNS 0.00
- Stochastic Oscillator
- PRZO 74.06
- JUNS 0.00
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.